Bausch Health Companies Inc (BHC.TO)
9.22
-0.42
(-4.36%)
CAD |
TSX |
May 17, 16:00
Bausch Health Enterprise Value: 33.55B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 33.55B |
| May 16, 2024 | 33.70B |
| May 15, 2024 | 33.71B |
| May 14, 2024 | 33.74B |
| May 13, 2024 | 33.74B |
| May 10, 2024 | 33.62B |
| May 09, 2024 | 33.66B |
| May 08, 2024 | 33.71B |
| May 07, 2024 | 33.91B |
| May 06, 2024 | 33.93B |
| May 03, 2024 | 34.08B |
| May 02, 2024 | 34.22B |
| May 01, 2024 | 34.58B |
| April 30, 2024 | 34.59B |
| April 29, 2024 | 34.62B |
| April 26, 2024 | 34.54B |
| April 25, 2024 | 34.49B |
| April 24, 2024 | 34.47B |
| April 23, 2024 | 34.44B |
| April 22, 2024 | 34.41B |
| April 19, 2024 | 34.55B |
| April 18, 2024 | 34.51B |
| April 17, 2024 | 34.54B |
| April 16, 2024 | 34.59B |
| April 15, 2024 | 34.53B |
| Date | Value |
|---|---|
| April 12, 2024 | 34.59B |
| April 11, 2024 | 34.67B |
| April 10, 2024 | 34.64B |
| April 09, 2024 | 34.77B |
| April 08, 2024 | 35.00B |
| April 05, 2024 | 35.36B |
| April 04, 2024 | 35.17B |
| April 03, 2024 | 35.15B |
| April 02, 2024 | 35.24B |
| April 01, 2024 | 35.35B |
| March 31, 2024 | 35.43B |
| March 28, 2024 | 34.94B |
| March 27, 2024 | 34.90B |
| March 26, 2024 | 34.59B |
| March 25, 2024 | 34.41B |
| March 22, 2024 | 34.45B |
| March 21, 2024 | 34.38B |
| March 20, 2024 | 34.42B |
| March 19, 2024 | 34.42B |
| March 18, 2024 | 34.34B |
| March 15, 2024 | 34.25B |
| March 14, 2024 | 34.18B |
| March 13, 2024 | 34.25B |
| March 12, 2024 | 34.21B |
| March 11, 2024 | 34.18B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
30.46B
Minimum
Jul 28 2022
45.14B
Maximum
Mar 11 2021
37.72B
Average
39.35B
Median
Sep 11 2020
Enterprise Value Benchmarks
| Bausch & Lomb Corp | 12.88B |
| Biocure Technology Inc | 1.448M |
| Core One Labs Inc | 8.808M |
| Nova Mentis Life Science Corp | 2.183M |
| Nanosphere Health Sciences Inc | 0.2445M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -86.28M |
| Revenue (Quarterly) | 2.902B |
| Total Expenses (Quarterly) | 2.506B |
| EPS Diluted (Quarterly) | -0.2292 |
| Gross Profit Margin (Quarterly) | 70.27% |
| Profit Margin (Quarterly) | -2.97% |
| Earnings Yield | -18.08% |
| Operating Earnings Yield | 66.83% |
| Normalized Earnings Yield | -2.547 |